- 1 On being a patient
- 2 Modern medicine: foundations, achievements, and limitations
- 3 Global patterns of disease and medical practice
- 4 Cell biology
- 5 Immunological mechanisms
- 6 Principles of clinical oncology
- 7 Infection
- 7.1 Pathogenic microorganisms and the host
- 7.2 The patient with suspected infection
- 7.3 Immunization
- 7.4 Travel and expedition medicine
- 7.5 Viruses
- 7.6 Bacteria
- 7.7 Fungi (mycoses)
- 7.8 Protozoa
- 7.9 Nematodes (roundworms)
- 7.9.1 Cutaneous filariasis
- 7.9.2 Lymphatic filariasis
- 7.9.3 Guinea worm disease (dracunculiasis)
- 7.9.4 Strongyloidiasis, hookworm, and other gut strongyloid nematodes
- 7.9.5 Gut and tissue nematode infections acquired by ingestion
- 7.9.6 Parastrongyliasis (angiostrongyliasis)
- 7.9.7 Gnathostomiasis
- 7.10 Cestodes (tapeworms)
- 7.11 Trematodes (flukes)
- 7.12 Nonvenomous arthropods
- 7.13 Pentastomiasis (porocephalosis, linguatulosis/linguatuliasis)
- 8 Sexually transmitted diseases and sexual health
- 9 Chemical and physical injuries and environmental factors and disease
- 10 Clinical pharmacology
- 11 Nutrition
- 12 Metabolic disorders
- 13 Endocrine disorders
- 14 Medical disorders in pregnancy
- 15 Gastroenterological disorders
- 16 Cardiovascular disorders
- 17 Critical care medicine
- 18 Respiratory disorders
- 19 Rheumatological disorders
- 20 Disorders of the skeleton
- 21 Disorders of the kidney and urinary tract
- 22 Disorders of the blood
- 23 Disorders of the skin
- 24 Neurological disorders
- 25 The eye
- 26 Psychiatry and drug related problems
- 27 Forensic medicine
- 28 Sports medicine
- 29 Geratology
- 30 Pain
- 31 Palliative medicine
- 32 Biochemistry in medicine
- 33 Acute medicine
(p. 1163) Strongyloidiasis, hookworm, and other gut strongyloid nematodes
- (p. 1163) Strongyloidiasis, hookworm, and other gut strongyloid nematodes
August 28, 2014: This chapter has been re-evaluated and remains up-to-date. No changes have been necessary.
Strongyloides diagnosis—development of real-time PCR assays; treatment—two doses of ivermectin may be better than one.
Hookworm control programmes—systematic review published.
Hookworm treatment—single-dose mebendazole less effective than albendazole.
Soil-transmitted helminth treatment in schoolchildren—failure to achieve WHO’s 2010 target.
Hookworm vaccine—results of phase I studies.
Hookworm immune modulation—maternal helminth infections may reduce neonatal atopic disease.
Oesophagostomiasis—impact of mass treatment campaigns.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.